Advertising is a major expenditure for pharmaceutical companies launching new products, but in the cutthroat European market, companies often try to gain competitive advantage by accusing competitors of engaging in false advertising. As a result, manufacturers can find themselves facing a lawsuit at the very onset of a product launch. Tanja Eisenblätter, litigation partner in Hogan Lovells’ Hamburg office, says that manufacturers operating in Europe should consider five key points when considering false advertising See more +

Advertising is a major expenditure for pharmaceutical companies launching new products, but in the cutthroat European market, companies often try to gain competitive advantage by accusing competitors of engaging in false advertising. As a result, manufacturers can find themselves facing a lawsuit at the very onset of a product launch. Tanja Eisenblätter, litigation partner in Hogan Lovells’ Hamburg office, says that manufacturers operating in Europe should consider five key points when considering false advertising claims.

See less -